Form 4: TransDigm Group Director Acquires Shares in Lieu of Fees
SEC Form 4 Filing
Director Jorge L. Valladares III acquired 27 shares of TransDigm Group INC common stock in lieu of a semi-annual director fee on March 26, 2025.
Summary
- On March 26, 2025, Jorge L. Valladares III, a director of TransDigm Group INC, acquired 27 shares of common stock.
- The acquisition was made in lieu of a semi-annual director fee, based on the fair market value of the stock according to the Director Share Plan.
- The price per share was $1,346.5.
- Following the transaction, Valladares directly owns 11,085 shares of TransDigm Group INC.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director taking shares in lieu of fees suggests confidence, but the transaction itself is routine.
Positives
- The director's decision to take shares in lieu of cash compensation demonstrates confidence in the company's future prospects.
Industry Context
Director share plans are a common method of compensating board members, aligning their interests with those of shareholders.
Related Party Transactions
- The receipt of stock in lieu of payment of semi-annual director fee is a related party transaction.
Stakeholder Impact
- The transaction has a minimal direct impact on stakeholders, but it signals the director's continued investment in the company.
Key Dates
| Date | Description |
|---|---|
| 03/26/2025 | Date of transaction: Director Jorge L. Valladares III acquired 27 shares of TransDigm Group INC common stock. |
Keywords
TransDigm Group INC, Director Share Plan, Form 4, Stock Acquisition, Insider Transaction, Valladares, Director Fee
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.